CYCC Company Report

Bio Green Med Solution, Inc. (formerly Cyclacel Pharmaceuticals, Inc.) closed the acquisition of Fitters Sdn. Bhd. on September 12, 2025, diversifying its business into fire protection and safety equipment while maintaining its pharmaceutical interests.
As a result of the transaction, the company's common stock ticker symbol changed from CYCC to BGMS and its preferred stock ticker symbol changed from CYCCP to BGMSP.
The acquisition involved issuing 699,158 shares of common stock to Fitters Parent, representing 19.99% of Bio Green Med Solution's issued and outstanding shares.

Sep 12, 2025, 10:07 AM

Cyclacel Pharmaceuticals, Inc. Amends Common Stock Purchase Warrants

CYCC

Proxy Vote Outcomes

Delisting/Listing Issues

Cyclacel Pharmaceuticals, Inc. issued amended and restated Series A, B, and C common stock purchase warrants on September 1, 2025.
The primary amendment is the removal of the Ownership Limitation, which previously restricted holders from exercising warrants if it resulted in ownership exceeding a certain percentage (e.g., 4.99%) without a stockholder vote.
This removal was approved by the company's Board of Directors and majority stockholders, effective July 28, 2025.
Each series (A, B, and C) of the amended warrants entitles the holder to purchase 218,000 shares of common stock.
The exercise prices are $7.65 per share for Series A, $9.00 per share for Series B, and $10.20 per share for Series C, with all warrants expiring on June 20, 2030.